Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 10.7912 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 10.8974 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 10.6062 | 98 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 11.0091 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.8983 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 10.5278 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 10.5711 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 10.7198 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 10.7112 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.6336 | 98 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 10.682 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.6533 | 98 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 10.7309 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.6405 | 98 |